Catch Up on Tesla Earnings -- WSJ
Dow Jones2026/10/22 15:05By Will Flannigan
Tesla's third-quarter earnings report and call last night gave investors and the public a closer look at how Elon Musk's electric-vehicle company is doing under the hood.
Here are some takeaways:
-- Revenue: $28.05 billion (roughly flat year-over-year)
-- Net income: $787 million
-- Capex: $4.73 billion in Q3. Full-year spending is now expected at $20 billion, down from $25 billion previously.
-- Deliveries: 486,532 vehicles (down 2% year-over-year)
-- Vision: Musk said the Optimus humanoid robot could ship to outside companies by the end of next year.
-- Robotaxis: The company is working on getting the two-seat Cybercab to customers by the end of this year.
-- The elephant in the room: Musk was quiet on SpaceX-Tesla merger mullings.
The thing everyone wants to know: When will SpaceX and Tesla tie the knot. Because the two Musk companies have seemingly been living together for quite some time. Learn more about how they're already tied at the hip.
Get a deeper look at Tesla's earnings here.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
October 22, 2026 11:05 ET (15:05 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tom Lee Says Yields Below 5% Mean the AI Selloff Is Nearly Over
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) will be listed on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 millions.
Lycia will issue 17.64 million shares at a price of $18 per share to raise $317.5 million.
Citi is bullish on Palantir (PLTR.US): U.S. government and commercial businesses jointly drive growth, Q3 revenue is expected to exceed expectations again
Citigroup maintains its "Buy" rating on Palantir and raises the target price from $245 to $250.
Despite its stock price being halved, Goldman Sachs maintains a Buy rating: Holding $10 billions in orders, CoreWeave (CRWV) faces a major test with several billions in financing
As a core manufacturer of AI computing power infrastructure, CoreWeave (CRWV.US) holds orders worth tens of billions and its business is expanding rapidly. However, capital expenditure pressure and financing gaps have become the main concerns of the market.
Crypto prices
More
